[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:adenoid-cystic-carcinoma":3},{"name":4,"total":5,"recruiting":5,"trials":6,"biomarkers":84,"states":85},"Adenoid Cystic Carcinoma",12,[7,14,21,28,34,40,47,53,60,66,72,78],{"nct_id":8,"title":9,"phases":10,"status":11,"updated_at":12,"content_modified":13},"NCT04883671","Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial",[],"RECRUITING","2026-08-26T02:15:59.318403Z","2026-05-05T02:43:28.297145Z",{"nct_id":15,"title":16,"phases":17,"status":11,"updated_at":19,"content_modified":20},"NCT06891560","A Study of Enfortumab Vedotin in People With Adenoid Cystic Carcinoma",[18],"Phase 2","2026-08-26T02:16:54.044282Z","2026-05-05T02:43:27.807983Z",{"nct_id":22,"title":23,"phases":24,"status":11,"updated_at":26,"content_modified":27},"NCT05774899","CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC",[25],"Phase 1\u002FPhase 2","2026-08-26T02:17:23.750999Z","2026-05-05T02:43:27.515680Z",{"nct_id":29,"title":30,"phases":31,"status":11,"updated_at":32,"content_modified":33},"NCT07162480","Phase II Trial of Puxitatug Samrotecan (AZD8205) in Advanced, Recurrent or Metastatic (R\u002FM) Aggressive Adenoid Cystic Carcinoma Subtype I (ACC-I)",[18],"2026-08-26T02:18:23.582895Z","2026-05-05T02:43:26.975667Z",{"nct_id":35,"title":36,"phases":37,"status":11,"updated_at":38,"content_modified":39},"NCT06805617","A Phase 2 Trial of Ivonescimab for Patients With Advanced, Metastatic Salivary Gland Cancers",[18],"2026-08-26T02:17:07.954622Z","2026-05-05T02:43:26.948837Z",{"nct_id":41,"title":42,"phases":43,"status":11,"updated_at":45,"content_modified":46},"NCT06462183","Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed\u002FRefractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)",[44],"Phase 1","2026-08-26T02:15:52.238965Z","2026-05-05T02:35:31.745832Z",{"nct_id":48,"title":49,"phases":50,"status":11,"updated_at":51,"content_modified":52},"NCT06118086","Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma",[25],"2026-08-26T02:16:11.347936Z","2026-04-29T02:57:57.070685Z",{"nct_id":54,"title":55,"phases":56,"status":11,"updated_at":58,"content_modified":59},"NCT05553782","Drug Screening Using Novel IMD in Salivary and Head and Neck Cancers",[57],"Early Phase 1","2026-08-26T02:18:20.384845Z","2026-05-05T02:43:28.567369Z",{"nct_id":61,"title":62,"phases":63,"status":11,"updated_at":64,"content_modified":65},"NCT05377996","A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors",[25],"2026-08-26T02:18:58.141497Z","2026-07-05T05:32:16.802263Z",{"nct_id":67,"title":68,"phases":69,"status":11,"updated_at":70,"content_modified":71},"NCT06021626","A Study of CRD3874-SI in People With Solid Tumors",[44],"2026-08-26T02:16:32.589113Z","2026-07-05T05:32:16.744495Z",{"nct_id":73,"title":74,"phases":75,"status":11,"updated_at":76,"content_modified":77},"NCT01473784","Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck",[],"2026-08-26T02:18:31.164304Z","2026-05-05T02:43:27.927811Z",{"nct_id":79,"title":80,"phases":81,"status":11,"updated_at":82,"content_modified":83},"NCT06805825","A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and\u002For Metastatic Solid Tumors Known to Express c-Kit",[44],"2026-08-26T02:16:33.772093Z","2026-05-05T02:43:27.274696Z",[],[86,90,94,98,102,106],{"state":87,"count":88,"slug":89},"Massachusetts",7,"massachusetts",{"state":91,"count":92,"slug":93},"Texas",6,"texas",{"state":95,"count":96,"slug":97},"New York",5,"new-york",{"state":99,"count":100,"slug":101},"Michigan",4,"michigan",{"state":103,"count":104,"slug":105},"California",3,"california",{"state":107,"count":104,"slug":108},"Virginia","virginia"]